Juvmo was designed to offer a reduction in motor symptoms, while reducing non-motor side effects, through its more selective ...
The Brighterside of News on MSN
Long-term air pollution exposure linked to Parkinson’s disease risk
A Cambridge review links long-term particle pollution with increased Parkinson’s risk while highlighting major research gaps.
AbbVie stock (ABBV) slipped slightly on Monday, down 0.29%, after the company announced a major regulatory win. The FDA ...
Although a clinical setback last year continues to loom in the background, AbbVie’s $8.7 billion bet on Cerevel Therapeutics ...
JUVMO™ is the first and only selective D1/D5 receptor agonist approved for adults with Parkinson's disease1 Taken once daily with or without levodopa therapy, JUVMO offers patients ...
A nationwide Finnish cohort study found that people with Parkinson's disease receive anti-osteoporosis medications at rates ...
Parkinson’s disease affects the brain and can impact movement, sleep, and digestion, among other functions. Medication can help relieve symptoms, but it cannot stop the progression of the disease, ...
Health and Me on MSN
CSIR-CCMB scientists find flu & COVID viruses may affect a protein linked to Parkinson’s disease
Researchers at CSIR-Centre for Cellular and Molecular Biology (CCMB) have found possible links between RNA viruses like ...
4d
AskBio’s bold ambition to help people with Parkinson’s disease look forward — and maybe even tango
"Among the aims of the research team is to better understand whether gene therapy may one day provide a different approach to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results